Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)

HKG:1167 Revenue

In the year 2025, Jacobio Pharmaceuticals Group had annual revenue of 53.53M CNY, down -65.62%. Jacobio Pharmaceuticals Group had revenue of 7.86M in the half year ending December 31, 2025, a decrease of -66.09%.

• Revenue: 53.53M CNY
• Revenue Growth: -65.62%
• P/S Ratio: 94.36
• Revenue / Employee: 273.09K CNY
• Employees: 196
• Market Cap: 5.62B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	53.53M	-102.18M	-65.62%
Dec 31, 2024	155.71M	92.19M	145.13%
Dec 31, 2023	63.52M	-32.23M	-33.66%
Dec 31, 2022	95.75M	-57.06M	-37.34%
Dec 31, 2021	152.81M	-333.48M	-68.58%